Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
24800 | 251 | 26.3 | 55% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ACTIVATED CARBON PARTICLES | Author keyword | 4 | 50% | 2% | 6 |
2 | LYMPH NODE TARGETING | Author keyword | 4 | 75% | 1% | 3 |
3 | LYMPHATIC TARGETING | Author keyword | 2 | 28% | 2% | 5 |
4 | LYMPHATIC DRUG DELIVERY | Author keyword | 1 | 50% | 1% | 2 |
5 | PITCH BASED SPHERICAL ACTIVATED CARBON | Author keyword | 1 | 50% | 1% | 2 |
6 | HAMDARD NANOBIOTECHNOL ADV | Address | 1 | 40% | 1% | 2 |
7 | DABUR DEV | Address | 1 | 33% | 1% | 2 |
8 | ANTI FILARIAL DRUGS | Author keyword | 1 | 50% | 0% | 1 |
9 | ANTIFILARIAL DRUG | Author keyword | 1 | 50% | 0% | 1 |
10 | ENDOLYMPHATIC THERAPY | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CHROMOLYMPHOGRAPHY | 9 | 83% | 2% | 5 |
2 | ENDOLYMPHATIC INJECTION | 4 | 75% | 1% | 3 |
3 | BLEOMYCIN OIL SUSPENSION | 3 | 60% | 1% | 3 |
4 | ACTIVATED CARBON PARTICLES | 2 | 22% | 3% | 8 |
5 | CARCINOMATOUS PERITONITIS | 1 | 50% | 1% | 2 |
6 | ENDOLYMPHATIC APPLICATION | 1 | 100% | 1% | 2 |
7 | DIAGNOSTIC AGENTS | 1 | 23% | 2% | 5 |
8 | ADMINISTERED DIAZEPAM | 1 | 50% | 0% | 1 |
9 | ARSENIC TRIOXIDE UPTAKE | 1 | 50% | 0% | 1 |
10 | CADMIUM RESPONSIVE PROTOONCOGENE | 1 | 50% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Lymphatic targeting with nanoparticulate system | 2001 | 105 | 29 | 62% |
Liposomes to target the lymphatics by subcutaneous administration | 2001 | 147 | 55 | 42% |
Drug concentrations in axillary lymph nodes after lymphatic chemotherapy on patients with breast cancer | 2004 | 11 | 7 | 57% |
Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles | 2011 | 46 | 49 | 24% |
Lymphatic system: a prospective area for advanced targeting of particulate drug carriers | 2014 | 6 | 120 | 18% |
Molecular Targeting of Liposomal Nano-Particles to Lymphatic System | 2011 | 12 | 60 | 33% |
TARGETING OF COLLOIDS TO LYMPH-NODES - INFLUENCE OF LYMPHATIC PHYSIOLOGY AND COLLOIDAL CHARACTERISTICS | 1995 | 90 | 36 | 28% |
Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapies | 2009 | 33 | 35 | 31% |
Lymphoid tissue targeting of anti-HIV drugs using liposomes | 2005 | 15 | 31 | 23% |
Intelligent nanoparticles for advanced drug delivery in cancer treatment | 2015 | 1 | 58 | 7% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HAMDARD NANOBIOTECHNOL ADV | 1 | 40% | 0.8% | 2 |
2 | DABUR DEV | 1 | 33% | 0.8% | 2 |
3 | RADIO PHARM | 1 | 50% | 0.4% | 1 |
4 | SURGPANCREAT DIS | 1 | 50% | 0.4% | 1 |
5 | NANOPHARMACOL NANOTOXICOL | 1 | 29% | 0.8% | 2 |
6 | ENGN INTERDISCIPLINARY SCI | 0 | 20% | 0.8% | 2 |
7 | BIOMAT DRUG DELIVERY REGENERAT MED | 0 | 33% | 0.4% | 1 |
8 | THYROID BREAST VASC SURG | 0 | 33% | 0.4% | 1 |
9 | DRUG DELIVERY CLIN LTD | 0 | 25% | 0.4% | 1 |
10 | GENET ENGN DEV | 0 | 25% | 0.4% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000249197 | LYMPHATIC SYSTEM MR//LYMPHOGRAPHY//INTERSTITIAL MR LYMPHOGRAPHY |
2 | 0.0000155316 | LIPOSOME//THERMOSENSITIVE LIPOSOMES//IMMUNOLIPOSOMES |
3 | 0.0000116078 | DRUG DELIVERY//GALACTOSYLATED LIPOSOMES//N SUCCINYL CHITOSAN |
4 | 0.0000073383 | SEDDS//SMEDDS//SELF MICROEMULSIFYING DRUG DELIVERY SYSTEM |
5 | 0.0000068578 | INTRAPERITONEAL CHEMOTHERAPY//INTRAPERITONEAL//INTRAPERITONEAL THERAPY |
6 | 0.0000067332 | LYMPH PUMP//CARDIOVASC LYMPHAT BIOL//LYMPHATIC SMOOTH MUSCLE |
7 | 0.0000063868 | PERITONEAL LAVAGE CYTOLOGY//J AN FOOD EDUC HLTH//PERITONEAL CYTOLOGY |
8 | 0.0000063365 | NANOCAPSULES//LIPID CORE NANOCAPSULES//POLYALKYLCYANOACRYLATE |
9 | 0.0000059164 | IMEXON//1 4 DIHYDRO 2 3 QUINOXALINEDIONE//CYANOAZIRIDINE |
10 | 0.0000057430 | DRUG DELIVERY DISPOSIT DYNAM GRP//2 3 5 6 TETRAMETHYL P PHENYLENEDIAMINE//ANESTHETICS DISSOCIATIVE |